GlassScriptPhysician profile
Jason J Jameson
NPI 1902865116
$3,061.60
in general payments reported to CMS, 2019-2025
22 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2021: $908 · 2022: $525 · 2023: $676 · 2024: $334 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $733.04 | 2021-2023 | |
| Cook Medical LLC | $291.06 | 2019-2024 | Fiber Dust, Cook |
| Endo Pharmaceuticals INC. | $230.03 | 2019 | |
| Progenics Pharmaceuticals, INC. | $199.42 | 2021 | |
| Antares Pharma, INC. | $190.57 | 2019-2023 | Tlando, Xyosted |
| Urogen Pharma, INC. | $141.75 | 2024 | |
| Axonics, INC. | $139.53 | 2024 | Bulkamid, Axonics |
| Olympus America INC. | $133.14 | 2023 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $131.89 | 2021-2022 | |
| Myovant Sciences INC. | $122.81 | 2021 | |
| Innovation Technologies INC | $116.02 | 2023 | Irrisept |
| Astellas Pharma US INC | $114.89 | 2025 | Padcev |
| Ambu INC. | $111.05 | 2022 | |
| Medtronic, INC. | $105.62 | 2023 | Interstim |
| Pfizer INC. | $100.06 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $79.63 | 2022 | |
| Blue Earth Diagnostics | $25.63 | 2025 | Posluma |
| Vertex Pharmaceuticals Incorporated | $20.88 | 2025 | |
| Coloplast Corp | $20.62 | 2024 | |
| Dendreon Pharmaceuticals LLC | $20.22 | 2025 | Provenge |
| Ethicon US, LLC | $20.17 | 2025 | Dermabond, Surgiflo Hemostatic Matrix |
| Astrazeneca Pharmaceuticals LP | $13.57 | 2024 | Onglyza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Jameson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.